fda flavored vapes

FDA Clarifies Age Verification Requirements for Flavored Vape Products: What Manufacturers Need to Know

The Food and Drug Administration (FDA) has provided additional clarification on how it evaluates flavored e-cigarette products, confirming that manufacturers do not necessarily need to incorporate electronic age-verification technology into their devices to receive marketing authorization. Although device access restrictions can help address concerns about underage vaping, the agency considers them one part of a broader public-health assessment rather than a universal requirement.

The clarification is particularly relevant for manufacturers developing flavored vape products and navigating the Premarket Tobacco Product Application (PMTA) process. It also provides insight into how the FDA evaluates different approaches to preventing youth access while considering applications for products intended for adults who smoke.

The agency's position was outlined in an October 26 letter from Bret Koplow, director of the FDA's Center for Tobacco Products (CTP), to Glas Inc. CEO Sean Greenbaum. The correspondence offers a closer look at the regulatory questions surrounding flavored products, age restrictions, and the evidence required for authorization.

Device Access Restrictions Are Not Mandatory for Every Application

The discussion began with a September 14 inquiry from Glas CEO Sean Greenbaum concerning device access restrictions, commonly abbreviated as DAR.

These restrictions are designed to prevent a vaping device from operating until its user completes an age-verification process. Depending on the technology, this may involve scanning a government-issued identification document or using a smartphone application to verify age and identity.

Glas wanted to understand whether the FDA considers this technology necessary when reviewing applications for flavored e-cigarettes.

In his October 26 response, Koplow clarified that device access restrictions are one consideration in the agency's evaluation of potential youth risks. They are not an automatic requirement for every flavored product seeking authorization.

This distinction is important because it suggests manufacturers may have different ways to address the FDA's concerns. A company could incorporate electronic age verification into its hardware, but it may also attempt to demonstrate that its product meets the applicable public-health standard through other evidence.

That flexibility does not eliminate the need to address youth access. It simply means that built-in age verification is not the only factor the agency considers.

FDA

Vuse Pro Pods Highlight the Difference Between Retail and Device Restrictions

The question of age verification became particularly relevant following R.J. Reynolds Vapor Company's introduction of flavored Vuse Pro pods.

The pods are designed to work with existing Vuse Alto devices, which do not include built-in electronic age-verification technology.

Reynolds, part of British American Tobacco, requires identification scanning when customers purchase the flavored Vuse Pro pods through retail channels. However, this measure does not prevent the pods from being used with a compatible Vuse Alto device once purchased.

The situation illustrates the difference between retail-level age restrictions and device-level access controls.

Retail identification scanning is intended to verify a customer's age at the point of sale. Device access restrictions go further by attempting to prevent operation without electronic verification.

The FDA authorized the Vuse Alto power unit and six tobacco-flavored pods in July 2024. However, the flavored Vuse Pro pods are not included on the agency's current list of authorized e-cigarette products.

This distinction is important for understanding the regulatory status of the products. Compatibility with previously authorized hardware does not automatically grant authorization to newly introduced pods.

fda age verification

Glas's Mango and Blueberry Pods Marked an Important Milestone

Glas has particular interest in the FDA's position because the company received authorization for four Glas G2 pods on May 5.

Two of the authorized products featured flavors outside the traditional tobacco and menthol categories: mango and blueberry.

These were the FDA's first marketing authorizations for e-cigarette flavors outside tobacco and menthol, making the decision a notable development for the flavored vape market.

The Glas G2 system uses smartphone-based age and identity verification to restrict device access. This technology provides an additional safeguard intended to address concerns about underage use.

However, the FDA's October clarification indicates that this particular approach is not necessarily required for other manufacturers seeking authorization for flavored products.

Companies may pursue different strategies, provided they can supply sufficient evidence to demonstrate that marketing their products would be appropriate for public health.

The Public-Health Standard Remains the Central Requirement

The FDA's March draft guidance on flavored e-cigarette applications provides additional context for understanding the agency's position.

Under the guidance, device access restrictions are treated as one factor in assessing potential youth risks rather than a universal prerequisite for approval.

Manufacturers must still demonstrate that their products meet the statutory standard of being appropriate for the protection of public health.

This requires the FDA to consider the potential benefits for adults who smoke alongside the risks to people who do not use tobacco products, including young people.

Consequently, adding age-verification technology does not guarantee that an application will receive authorization. Manufacturers must provide evidence addressing the broader public-health considerations associated with their products.

Similarly, the absence of built-in age restrictions does not automatically disqualify a product from consideration.

The agency evaluates the overall application rather than relying on one technological feature as the sole measure of youth protection.

Enforcement Discretion Is Not the Same as Marketing Authorization

Another important distinction involves the FDA's enforcement policies.

The agency's May enforcement guidance identifies circumstances in which it may deprioritize enforcement against certain products with pending applications.

However, enforcement discretion should not be confused with actual marketing authorization. A product that receives a lower enforcement priority has not necessarily been approved for sale.

The FDA has also not publicly established whether the flavored Vuse Pro pods qualify under this particular policy.

For manufacturers, distributors, and retailers, understanding this distinction is essential. A pending PMTA and a decision not to prioritize enforcement do not carry the same regulatory status as an approved application.

Legal Challenges Could Reshape the PMTA Framework

The FDA's clarification comes amid broader legal questions surrounding its review process.

On August 19, the Fifth Circuit Court of Appeals ruled that the agency had improperly imposed its comparative-efficacy standard without following the required notice-and-comment rulemaking process.

The decision challenged part of the FDA's approach to evaluating premarket applications and added uncertainty to an already complicated regulatory environment.

In September, the agency indicated that it intended to consider replacing its 2021 PMTA framework. Potential changes could affect the evidence manufacturers are expected to submit and the standards used to evaluate future applications.

fda age verification

What This Means for the Future of Flavored Vapes

The FDA's October clarification provides an important distinction for manufacturers: Built-in electronic age verification may strengthen an application, but it is not a universal condition for receiving marketing authorization.

Companies can explore different approaches to addressing youth-access concerns, provided they demonstrate that their products meet the public-health standard.

However, the clarification should not be interpreted as a relaxation of the FDA's authorization requirements. Flavored products still face substantial regulatory scrutiny, and neither device compatibility nor a pending application automatically makes an unauthorized product eligible for legal marketing.

For the vaping industry, the agency's position offers additional flexibility in product development and regulatory strategy. The remaining challenge is demonstrating that alternative safeguards and supporting evidence are sufficient to satisfy the FDA's expectations.

Back to blog